Edwards Lifesciences Corp (EW) Form 4 Filed by Andrew M. Dahl, Nov 14, 2026

SEC Form 4 · No Market Transaction
Tax Withholding

Shares withheld for tax obligations.

Reporting Owner
TXN 2026-11-13 · FILED 2026-11-14
Equity Position 14.6K sh 14,706 → 14,605
Equity Change -0.7% shares held after vs before
Filing Lag 0 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-11-14
Report Date
2026-11-14
Accession No.
0001225208-26-009012
Accepted At
2026-11-14 01:21 UTC
Reporting Owner
Name Relationship
Andrew M. Dahl CIK 0002022347
SVP
Andrew M. Dahl at Edwards Lifesciences Corp Full insider history
Bought (12 mo) —
Sold (12 mo) $98,341
More from this insider at Edwards Lifesciences Corp
All filings by this insider at Edwards Lifesciences Corp
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1 2026-11-13 F - Tax Payment 101 D $105.80 -$10,686 14,605.7777 Direct
Footnotes (1)
F1
Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e). Show more
Remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.

Show more
5%+ Holders · 13D/G 2 filers
Other insiders at Edwards Lifesciences Corp
All Edwards Lifesciences Corp insider activity
GET /v1/forms/4/0001225208-26-009012 API docs
View Original SEC Filing